GENEVA, May 27 -- SIA "EMTEKO HOLDING" (Aizputes iela, 2ALV-1046 Riga) filed a patent application (PCT/IB2024/061418) for "PHARMACEUTICAL COMPOSITION COMPRISING EDARAVONE FOR USE IN REDUCING LEVELS OF IL-6 AND TNF-ALPHA INFLAMMATORY MARKERS AND REDUCING TIME TO WITHDRAWAL OF OXYGEN THERAPY IN PATIENTS WITH INFECTIOUS DISEASES" on Nov 15, 2024. With publication no. WO/2025/104696, the details related to the patent application was published on May 22, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): GUMENIUK, Mykola (Klinichna str., 23-25, ap. 173Kyiv, 03110)
Abstract:
The disclosure refers ...